Stockreport

Wall Street Analysts See a 101.81% Upside in Lyra Therapeutics (LYRA): Can the Stock Really Move This High? [Yahoo! Finance]

Lyra Therapeutics, Inc.  (LYRA) 
PDF left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $12.25 indicates a 101.8% upside potential. The mean [Read more]